BeOne Medicines AG (ONC) — Stock Score Summary

BeOne Medicines AG (ONC) has a MoatMap StockRank of 72/100 based on Quality (74/100), Value (22/100), and Momentum (58/100) factor scores. The current signal is BUY. BeOne Medicines AG lacks sufficient public market intelligence and clear alignment with our active macro themes. We default to remove to maintain our high-conviction threshold.

BeOne Medicines AG, while not publicly traded under the provided ticker and country combination, is likely a pharmaceutical or biotechnology company focused on developing novel medical treatments. Its competitive edge would stem from proprietary research, specialized drug pipelines, and a focus on addressing unmet medical needs. This positions it as an innovative player aiming to bring new therapies to market within the healthcare sector.

Key Financial Metrics

Price$279.00
Market Cap$30.1B
P/E (TTM)63.33
P/E (Forward)28.98
Price/Book6.53
Return on Equity12.4%
Return on Invested Capital7.5%
Debt/Equity24.14
Gross Margin88.3%
Operating Margin16.5%
Revenue Growth35.5%
Free Cash Flow$917M

BeOne Medicines AG operates in the Biotechnology industry, part of the Healthcare sector (Switzerland).

Frequently Asked Questions

What is BeOne Medicines AG’s (ONC) StockRank?
MoatMap’s StockRank for BeOne Medicines AG (ONC) is 72/100, with a Buy signal. It is a composite of Quality (74), Value (22), and Momentum (58) factor ranks across MoatMap’s 19,000+ stock universe.
Does BeOne Medicines AG have an economic moat?
BeOne Medicines AG (ONC) has a Quality factor score of 74/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is BeOne Medicines AG a buy, hold, or sell?
MoatMap’s current signal for BeOne Medicines AG (ONC) is Buy, based on a StockRank of 72/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is BeOne Medicines AG in?
BeOne Medicines AG (ONC) operates in the Healthcare sector, specifically the Biotechnology industry (Switzerland).
Browse all ranked stocksONC deep dive reportAI ChampionsHow we score stocksSense-check another stock